Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments
Contributeurs/tricesQuteineh, Lina; Vandenberghe, Frederik; Saigi Morgui, Nuria; Delacrétaz, Aurélie; Choong, Eva; Gholam-Rezaee, Mehdi; Magistretti, Pierre; Bondolfi, Guido; Von Gunten, Armin; Preisig, Martin; Castelao, Enrique; Vollenweider, Peter; Waeber, Gerard; Bochud, Murielle; Kutalik, Zoltán; Conus, Philippe; Eap, Chin Bin
Publié dansPharmacogenetics and genomics, vol. 25, no. 5, p. 246-258
Date de publication2015
Résumé
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
QUTEINEH, Lina et al. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments. In: Pharmacogenetics and genomics, 2015, vol. 25, n° 5, p. 246–258. doi: 10.1097/FPC.0000000000000131
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:78753
- DOI : 10.1097/FPC.0000000000000131
- PMID : 25751397
ISSN du journal1744-6872
